News Briefs – NDNR

1. Ortho Molecular Products announces support for naturopathic residency consortium BARRINGTON, IL (April 8, 2022) — Ortho Molecular Products is proud to announce a partnership with Institute for Natural Medicine (INM) and its Residency Consortium, a premier, sustainable residency model for top naturopathic doctor (ND) graduates. The goal is to create a residency cohort model […]

5 Myths About CBD

Sarah Cimperman, ND Cannabidiol, better known as CBD, has been marketed as a natural cure for conditions ranging from anxiety and insomnia to epilepsy and chronic pain. At a time when ninety percent of people in the United States believe that the cannabis plant has medical benefits, CBD product sales are surging.1 Market researchers predict […]

CBD Helps Anxiety in Those Suffering with Substance Addiction

Razi Berry Cannabidiol (CBD) reduced cue-induced craving and anxiety in individuals with a history of heroin abuse, suggesting a potential role for it in helping to break the cycle of addiction, according to research conducted at the Icahn School of Medicine at Mount Sinai and published May 21 in the American Journal of Psychiatry. The […]

Warning: Online Cannabis Oils Could Contain More THC Than What’s Labeled

Razi Berry One of the biggest concerns/confusions of potential consumers of CBD products is whether they can trust that the product does not contain the psychoactive constituent THC. Many CBD products are labeled as “hemp,” and are not supposed to have more than 0.3% THC. However, “cannabis,” “hemp,” and “marijuana” all come from the same […]

Cannabis Use in Children with Epilepsy

Razi Berry A recent research study on the use of cannabis in treatment-resistant forms of epilepsy differs from previously held beliefs about CBD versus THC.1 The study, conducted in Australia, found that parents treating children with medical cannabis extracts saw a great reduction in epileptic symptoms, up to 75 percent, however, products surprisingly contained relatively […]

FDA Approves Cannabidiol for Use in Epilepsy

Node Smith, ND On April 19, 2018, an advisory panel from the Federal Food and Drug Administration (FDA) recommended a new drug to be approved for the treatment of epilepsy.1 The drug, Epidiolex, produced by GW Pharmaceuticals in Britain, is a pure oral solution of cannabidiol, one of the primary endocannabinoids found in the herb […]

Mislabeling of CBD Products

Node Smith, ND Study States Nearly 70% of CBD Products Sold are Mislabeled A recent study from Penn State has found that nearly 70 percent of CBD products sold are mislabeled as to the amount of CBD contained.1 The mislabeling apparently goes in both directions, with some products containing more CBD than labeled, and others […]